Adeshwar Meditex (BOM:543309) EBIT: ₹24.4 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543309 Adeshwar Meditex Ltd BOM:543309
63 GF Score
Price ₹16.30
GF Value ₹15.09
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Adeshwar Meditex EBIT?

Adeshwar Meditex BOM:543309 63 EBIT is ₹24.4 Mil as of Mar. 2026. GuruFocus rates BOM:543309 with a GF Score™ of 63/100 and a GF Value™ of ₹15.09 (Fairly Valued). The stock has 7 warning signs investors should review.

Adeshwar Meditex's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was ₹10.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹24.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Adeshwar Meditex's annualized ROC % for the quarter that ended in Mar. 2026 was 2.94%. Adeshwar Meditex's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 5.52%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Adeshwar Meditex's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 8.28%.


Adeshwar Meditex  (BOM:543309) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Adeshwar Meditex's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=20.236 * ( 1 - 34.57% )/( (446.195 + 453.796)/ 2 )
=13.2404148/449.9955
=2.94 %

where

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Adeshwar Meditex's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=21.27/( ( (28.112 + max(358.539, 0)) + (26.091 + max(358.472, 0)) )/ 2 )
=21.27/( ( 386.651 + 384.563 )/ 2 )
=21.27/385.607
=5.52 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(324.821 + 218.393 + 0.17300000000012) - (180.38 + 0 + 4.468)
=358.539

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(208.189 + 205.008 + 0.19799999999998) - (48.254 + 0 + 6.669)
=358.472

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Adeshwar Meditex's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=24.42/295.066
=8.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adeshwar Meditex EBIT Related Terms


Adeshwar Meditex EBIT Historical Data

* Premium members only.

The historical data trend for Adeshwar Meditex's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adeshwar Meditex EBIT Chart

Adeshwar Meditex Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only 31.30 48.57 45.04 41.27 24.42

Adeshwar Meditex Semi-Annual Data
Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.05 19.61 21.28 13.79 10.64

BOM:543309 vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Adeshwar Meditex's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adeshwar Meditex EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adeshwar Meditex's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Adeshwar Meditex's EV-to-EBIT falls into.


BOM:543309
63GF Score
Adeshwar Meditex Ltd BOM:543309
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adeshwar Meditex EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹24.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹24.4 Mil mean?
Adeshwar Meditex (BOM:543309) has a EBIT of ₹24.4 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Adeshwar Meditex.
Is Adeshwar Meditex's EBIT too high?
Adeshwar Meditex's current EBIT is ₹24.4 Mil. Overall, Adeshwar Meditex has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adeshwar Meditex's EBIT compare to ISRG and BDX?
Adeshwar Meditex's EBIT of ₹24.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Adeshwar Meditex. Adeshwar Meditex's current EBIT is ₹24.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adeshwar Meditex stock overvalued right now?
Based on GuruFocus' analysis, Adeshwar Meditex (BOM:543309) is currently considered Fairly Valued. The stock's GF Value™ is ₹15.09, compared to a current price of ₹16.30 — trading 8% above its estimated fair value. The current EBIT is ₹24.4 Mil. Adeshwar Meditex's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Adeshwar Meditex (BOM:543309), the current EBIT is ₹24.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adeshwar Meditex (BOM:543309) Overvalued in 2026?

Based on GuruFocus' analysis, Adeshwar Meditex stock appears to be overvalued. The current stock price of ₹16.30 is trading 8% above its estimated GF Value™ of ₹15.09. GuruFocus considers Adeshwar Meditex to be Fairly Valued.

Key valuation signals for BOM:543309:

  • EBIT: ₹24.4 Mil
  • GF Value™: ₹15.09 vs. price of ₹16.30 (8% above fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the BOM:543309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Adeshwar Meditex Business Description

Address Marol Maroshi Road, Gala 111 Lok Centre, Andheri East, Marol Naka, Mumbai, MH, IND, 400059
Adeshwar Meditex Ltd is engaged in manufacturing surgical dressings and external preparations products such as Sterile surgical wound dressing, Combine dressing, Gauze Dressing and Cotton Products, Medical Bandages and Plaster, Antiseptics / Disinfectants, and others.
63GF Score

Get the complete analysis for BOM:543309

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹16.30
Price
₹15.09
GF Value